Nyree Crawford

Biochemistry, Genetics and Molecular Biology · Life Sciences

23h-index1.7kcitations100works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell death mechanisms and regulation(27), Histone Deacetylase Inhibitors Research(17), Cancer, Hypoxia, and Metabolism(16), Cancer-related Molecular Pathways(12), Colorectal Cancer Treatments and Studies(11)

Publications100 total

Figure 5 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
Figure 4 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
Figure 3 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
Figure 2 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
Figure 1 from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2025Open Access
USP7 inhibitors suppress tumour neoangiogenesis and promote synergy with immune checkpoint inhibitors by downregulating fibroblast VEGF
Clinical and Translational Medicine·2024· 11 citedOpen Access
Supplementary Figure from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Supplementary Data from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Supplementary Figure 1 from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 3 from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 4 from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 3 from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Data from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 1 from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Data from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Supplementary Figure Legends from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
Supplementary Figure 4 from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Supplementary Figure 2 from FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
2023Open Access
Data from Functional Genomic Identification of Predictors of Sensitivity and Mechanisms of Resistance to Multivalent Second-Generation TRAIL-R2 Agonists
2023Open Access
page 1 of 5Next →

Frequent Co-authors

Daniel B. Longley(33), Patrick G. Johnston(18), Caitriona Holohan(14), Simon S. McDade(11), Joanna Majkut(10), Christopher McCann(9), Paul B. Mullan(8), Catherine Higgins(8), Izabela Stasik(8), Niamh E. Buckley(7), Sandra Van Schaeybroeck(7), Jochen H.M. Prehn(7), Mark Wappett(7), Jamie Z. Roberts(6), Richard D. Kennedy(6), Mark Lawler(6), Tamas Sessler(6), Andrea Lees(6), Katherine McAllister(6), D. Paul Harkin(5)